Trials / Sponsors / CytoVac A/S
CytoVac A/S
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients Glioblastoma | Phase 2 | 2016-03-01 |
| Terminated | Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/ Glioblastoma Multiforme | Phase 2 | 2014-02-01 |
| Completed | A Prospective, Open Phase I Study to Investigate the Tolerability and Efficacy of ALECSAT to Pancreas Cancer P Pancreatic Cancer | Phase 1 | 2013-10-01 |
| Completed | Safety Study of Repeated Dosing of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy Hormone-refractory Prostate Cancer | Phase 1 | 2011-08-01 |
| Completed | A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Pa Glioblastoma Multiforme | Phase 1 | 2011-08-01 |
| Completed | Safety Study of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy Hormone-refractory Prostate Cancer | Phase 1 | 2009-04-01 |